Amphastar Pharmaceuticals Inc (AMPH)
38.33
-0.23
(-0.60%)
USD |
NASDAQ |
Jul 05, 09:34
Amphastar Pharmaceuticals Net Income (Annual): 137.54M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 137.54M |
December 31, 2022 | 91.39M |
December 31, 2021 | 62.12M |
December 31, 2020 | 1.403M |
December 31, 2019 | 48.94M |
December 31, 2018 | -5.738M |
December 31, 2017 | 3.647M |
Date | Value |
---|---|
December 31, 2016 | 9.82M |
December 31, 2015 | -2.787M |
December 31, 2014 | -10.70M |
December 31, 2013 | 11.86M |
December 31, 2012 | 18.09M |
December 31, 2011 | 7.752M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
1.403M
Minimum
2020
137.54M
Maximum
2023
68.28M
Average
62.12M
Median
2021
Net Income (Annual) Benchmarks
Eli Lilly and Co | 5.240B |
Biogen Inc | 1.161B |
Pfizer Inc | 2.119B |
Anavex Life Sciences Corp | -47.50M |
Corvus Pharmaceuticals Inc | -27.03M |